LOS ANGELES, April 22 /PRNewswire/ -- Ceres, Inc., a leading biotechnology company developing high value plants and plant-based products to benefit human health and agriculture has obtained a commercial license from Japan Tobacco Inc. for a proprietary transformation system known as PureIntro(TM). Terms of the agreement were not disclosed.
"We are very pleased to have secured a license to PureIntro(TM) technology. This is an important tool for commercializing high-value plants and plant-based products," stated Richard Flavell, the Chief Scientific Officer of Ceres. He added, "Ceres has identified the biological roles of thousands of genes related to crop traits using its large collection of full-length cDNAs. Ceres is now moving rapidly to designing breakthrough traits. Having access to the PureIntro(TM) transformation technology will speed up our product development efforts in many economically valuable crops."
About Ceres, Inc.
Ceres, Inc. is a privately held biotechnology company utilizing multiple integrated plant genomics technologies to develop innovative products. In addition to pursuing opportunities in the food, feed and fiber industries, Ceres' business strategy consists of leveraging its technology platform in the agrochemical, chemical and pharmaceutical industries. For more information visit our web site at http://www.ceresbiotechnology.com/
About Japan Tobacco Inc.
Japan Tobacco Inc. is the world's third largest international manufacturer of tobacco products. The company manufactures internationally recognized cigarette brands including Camel, Winston, Mild Seven and Salem. Since its privatization in 1985, JT has actively diversified its operations into pharmaceuticals and foods. The company net sales were JPY 4.492 trillion in the fiscal year ended March 31, 2003.
CONTACT: Peter Mascia, Vice President of Business Development of Ceres,Inc., +1-310-317-8900